Skip to content
PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 616

616. Deputy Michael Cahill asked the Minister for Health if she is aware of concerns that some people living with Friedreich’s ataxia may face significant delays in accessing skyclarys (omaveloxolone) despite its reimbursement from 1 October 2026 due to capacity constraints at the combined ataxia clinic at Tallaght University Hospital; the estimated timeframe within which all eligible patients will have commenced treatment; if additional resources will be provided to support treatment initiation and monitoring; the current waiting time for a Friedreich’s ataxia clinic appointment; and the measures being taken. [70235/26]

askedIreland· Dáil Éireann· EN

Introduced

6 October 2026

Last action

6 October 2026 · Medicinal Products

Status

written

Sponsors

Michael Cahill

Subjects

Discovery layer

Source updated

6 October 2026

Summary

616. Deputy Michael Cahill asked the Minister for Health if she is aware of concerns that some people living with Friedreich’s ataxia may face significant delays in accessing skyclarys (omaveloxolone) despite its reimbursement from 1 October 2026 due to capacity constraints at the combined ataxia clinic at Tallaght University Hospital; the estimated timeframe within which all eligible patients will have commenced treatment; if additional resources will be provided to support treatment initiation and monitoring; the current waiting time for a Friedreich’s ataxia clinic appointment; and the measures being taken. [70235/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 6 October 2026

    Medicinal Products

    616. Deputy Michael Cahill asked the Minister for Health if she is aware of concerns that some people living with Friedreich’s ataxia may face significant delays in accessing skyclarys (omaveloxolone) despite its reimbursement from 1 October 2026 due to capacity constraints at the combined ataxia clinic at Tallaght University Hospital; the estimated timeframe within which all eligible patients will have commenced treatment; if additional resources will be provided to support treatment initiation and monitoring; the current waiting time for a Friedreich’s ataxia clinic appointment; and the measures being taken. [70235/26]

    Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products

View fileDownload file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.